Maastricht, The Netherlands, October 23, 2013 / B3C newswire / -PharmaCell announced today that it has entered into an agreement with Dendreon Corporation (NASDAQ: DNDN) to be the Contract Manufacturing Organization (CMO) for the European commercial production of its recently approved cellular immunotherapy product Provenge® (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or sipuleucel-T) dispersion for infusion.
Ummmm hello....Did any money change hands here? Did dudreon get any cash infusion from this? This "newz" will do zilcho for the PPS. Of course they found somebody to make it, that person will make money. This is the same as posting "I found a place to make my trades"....No money went into your trading account, and they will make money off of you, so what's the big deal?
Does anyone here remember they had to close one manufacturing plant in the states already? Manufacturing plants don't make money unless there is a demand for a product. It doesn't matter that they found somebody to take their money to produce a product nobody wants. Until somebody antes up with a freaking boat load of cash, and infuses it into DNDN's account, they could announce a hundred deals like this and it won't matter a bit.
You are right, Pharma Cell will only handle the manufacturing and the logistics. But who will sell Provenge in Europe is still not clear. It may be Dendreon or maybe they find a partner who will sell it. We will see. It would be better they find a partner to sell it.
PharmaCell is a leading European-based CMO active in the area of cell therapy and regenerative medicine. PharmaCell has experience in supporting Phase I-III clinical trials, as well as commercialization projects, in terms of manufacturing, QC, QP batch certification, storage, in-outgoing logistics. The company is exclusively focused on providing contract services in the area of human cell therapy. Its services include process and assay-development to ensure GMP compliance, robustness and scalability of cell therapy manufacturing processes. PharmaCell operates a state-of-the art cGMP certified facility situated in Maastricht, The Netherlands, centrally located in Europe. The facility covers 1400 square meters including clean rooms, grade A, B, C and D (Classes 100/10.000/100.000), R&D and QC laboratories including cryopreservation, warehouse and logistics areas.
Strange no news on Yahoo or any of the Hedge monkey fish raps. The MM's aren't letting the monkeys out of their cages. Now that JJ is going it alone he better find some money or sales better turn.